Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/27887
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Johnson, Chris F | en_UK |
dc.contributor.author | Ali Nassr, Ola | en_UK |
dc.contributor.author | Harpur, Catherine | en_UK |
dc.contributor.author | Kenicer, David | en_UK |
dc.contributor.author | Thom, Alex | en_UK |
dc.contributor.author | Akram, Gazala | en_UK |
dc.date.accessioned | 2018-10-03T00:00:25Z | - |
dc.date.available | 2018-10-03T00:00:25Z | - |
dc.date.issued | 2018-09-30 | en_UK |
dc.identifier.other | 1256 | en_UK |
dc.identifier.uri | http://hdl.handle.net/1893/27887 | - |
dc.description.abstract | Background: Benzodiazepine and z-hypnotic prescribing has slowly decreased over the past 20 years, however long-term chronic prescribing still occurs and is at odds with prescribing guidance. Objectives: To identify the pattern of benzodiazepine and z-hypnotic prescribing in psychiatric inpatients at discharge and 12 months post-discharge. Methods: Retrospective observational longitudinal cohort study of patients admitted to two adult psychiatric wards between June and November 2012 (inclusive) who were discharged with a prescription for a benzodiazepine or z-hypnotic drug. Routinely collected prescription data available from NHS Scotland Prescribing Information System was used to identify and follow community prescribing of benzodiazepine and z-hypnotics for a 12 month period post-discharge. Data were entered in Excel® and further analysed using SPSS 23. Ethical approval was not required for this service evaluation however Caldicott Guardian approval was sought and granted. Results: Eighty patients were admitted during the study period however only those patients with a single admission were included for analysis (n=74). Thirty per cent (22/74) of patients were prescribed a benzodiazepine or z-hypnotics at discharge; 14 of whom received ‘long-term’ benzodiazepine and z-hypnotics i.e. continued use over the 12 month period. Seven patients received a combination of anxiolytics and hypnotics (e.g., diazepam plus temazepam or zopiclone). Long-term use was associated with a non-significant increase in median benzodiazepine or z-hypnotic dose, expressed as diazepam equivalents. Conclusions: One in three patients were prescribed a benzodiazepine or z-hypnotics at discharge with 1 in 5 receiving continuous long-term treatment (prescriptions) for 12 months post-discharge. As chronic long-term B-Z prescribing and use still remains an issue, future strategies using routine patient-level prescribing data may support prescribers to review and minimise inappropriate long-term prescribing. | en_UK |
dc.language.iso | en | en_UK |
dc.publisher | Centro de Investigaciones y Publicaciones Farmaceuticas (CIPF) | en_UK |
dc.relation | Johnson CF, Ali Nassr O, Harpur C, Kenicer D, Thom A & Akram G (2018) Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community. Pharmacy Practice, 16 (3), Art. No.: 1256. https://doi.org/10.18549/PharmPract.2018.03.1256 | en_UK |
dc.rights | Article distributed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) license (https://creativecommons.org/licenses/by-nc-nd/3.0/). | en_UK |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | en_UK |
dc.subject | Benzodiazepines | en_UK |
dc.subject | Patient Discharge | en_UK |
dc.subject | Practice Patterns, Physicians' | en_UK |
dc.subject | Psychiatric Department, Hospital | en_UK |
dc.subject | Psychiatry | en_UK |
dc.subject | Retrospective Studies | en_UK |
dc.subject | United Kingdom | en_UK |
dc.title | Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community | en_UK |
dc.type | Journal Article | en_UK |
dc.identifier.doi | 10.18549/PharmPract.2018.03.1256 | en_UK |
dc.citation.jtitle | Pharmacy Practice | en_UK |
dc.citation.issn | 1886-3655 | en_UK |
dc.citation.issn | 1886-3655 | en_UK |
dc.citation.volume | 16 | en_UK |
dc.citation.issue | 3 | en_UK |
dc.citation.publicationstatus | Published | en_UK |
dc.citation.peerreviewed | Refereed | en_UK |
dc.type.status | VoR - Version of Record | en_UK |
dc.contributor.funder | NHS Greater Glasgow & Clyde | en_UK |
dc.citation.date | 26/09/2018 | en_UK |
dc.contributor.affiliation | Health Sciences Stirling | en_UK |
dc.contributor.affiliation | Al-Mustansiriya University | en_UK |
dc.contributor.affiliation | NHS Greater Glasgow & Clyde | en_UK |
dc.contributor.affiliation | NHS Greater Glasgow & Clyde | en_UK |
dc.contributor.affiliation | NHS Greater Glasgow & Clyde | en_UK |
dc.contributor.affiliation | University of Strathclyde | en_UK |
dc.identifier.wtid | 1011536 | en_UK |
dc.contributor.orcid | 0000-0002-6006-6605 | en_UK |
dc.contributor.orcid | 0000-0002-3409-0150 | en_UK |
dc.contributor.orcid | 0000-0003-3207-8091 | en_UK |
dc.date.accepted | 2018-07-21 | en_UK |
dcterms.dateAccepted | 2018-07-21 | en_UK |
dc.date.filedepositdate | 2018-10-02 | en_UK |
rioxxterms.apc | not required | en_UK |
rioxxterms.type | Journal Article/Review | en_UK |
rioxxterms.version | VoR | en_UK |
local.rioxx.author | Johnson, Chris F|0000-0002-6006-6605 | en_UK |
local.rioxx.author | Ali Nassr, Ola|0000-0002-3409-0150 | en_UK |
local.rioxx.author | Harpur, Catherine| | en_UK |
local.rioxx.author | Kenicer, David| | en_UK |
local.rioxx.author | Thom, Alex| | en_UK |
local.rioxx.author | Akram, Gazala|0000-0003-3207-8091 | en_UK |
local.rioxx.project | Project ID unknown|NHS Greater Glasgow & Clyde| | en_UK |
local.rioxx.freetoreaddate | 2018-10-02 | en_UK |
local.rioxx.licence | http://creativecommons.org/licenses/by-nc-nd/3.0/|2018-10-02| | en_UK |
local.rioxx.filename | Johnson-etal-PharmPractice-2018.pdf | en_UK |
local.rioxx.filecount | 1 | en_UK |
local.rioxx.source | 1886-3655 | en_UK |
Appears in Collections: | Faculty of Health Sciences and Sport Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Johnson-etal-PharmPractice-2018.pdf | Fulltext - Published Version | 660.1 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
A file in this item is licensed under a Creative Commons License
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.